"Kidney Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes of the KIDNEY or its component tissues.
| Descriptor ID |
D007674
|
| MeSH Number(s) |
C12.777.419 C13.351.968.419
|
| Concept/Terms |
Kidney Diseases- Kidney Diseases
- Disease, Kidney
- Diseases, Kidney
- Kidney Disease
|
Below are MeSH descriptors whose meaning is more general than "Kidney Diseases".
Below are MeSH descriptors whose meaning is more specific than "Kidney Diseases".
This graph shows the total number of publications written about "Kidney Diseases" by people in this website by year, and whether "Kidney Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 2 | 4 |
| 2007 | 6 | 1 | 7 |
| 2008 | 3 | 2 | 5 |
| 2010 | 4 | 0 | 4 |
| 2011 | 4 | 0 | 4 |
| 2012 | 3 | 1 | 4 |
| 2013 | 3 | 0 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 2 | 4 |
| 2016 | 8 | 5 | 13 |
| 2017 | 79 | 32 | 111 |
| 2018 | 69 | 28 | 97 |
| 2019 | 44 | 9 | 53 |
| 2020 | 20 | 12 | 32 |
| 2021 | 11 | 3 | 14 |
To return to the timeline, click here.
Below are the most recent publications written about "Kidney Diseases" by people in Profiles.
-
Kidney Outcomes in Long COVID. J Am Soc Nephrol. 2021 11; 32(11):2851-2862.
-
Angiotensin-converting enzyme 2 decreased expression during kidney inflammatory diseases: implications to predisposing to COVID-19 kidney complications. Kidney Int. 2021 11; 100(5):1138-1140.
-
[Anti-SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases. Recommendations of the Italian Society on Nephrology's Working Group on Renal Immunopathology (Vaccine Task Force)]. G Ital Nefrol. 2021 Aug 30; 38(4).
-
Overview of acute kidney manifestations and management of patients with COVID-19. Am J Physiol Renal Physiol. 2021 10 01; 321(4):F403-F410.
-
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients. Clin Exp Nephrol. 2022 Jan; 26(1):75-85.
-
Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19. PLoS One. 2021; 16(8):e0255811.
-
Impact of the COVID-19 pandemic on interest in renal diseases. Environ Sci Pollut Res Int. 2022 Jan; 29(1):711-718.
-
Abdominal Pain Due to Renal Infarction: An Unexpected Presentation of COVID-19. R I Med J (2013). 2021 Aug 02; 104(6):16-19.
-
Renal manifestations, incidence, pathogenesis and implications on prognosis and mortality in COVID-19 patients: A review of current evidence and the potential for future directions. Clin Nephrol. 2021 Aug; 96(2):67-81.
-
COVID-19 induced collapsing glomerulopathy and role of APOL1. QJM. 2021 07 28; 114(4):263-264.